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Background: Spasticity in the upper limb is common after acquired brain impairment and may have a significant
impact on the ability to perform meaningful daily activities. Traditionally, outcome measurement in spasticity
rehabilitation has focused on impairment, however, improvements in impairments do not necessarily translate to
improvements in an individual’s ability to perform activities or engage in life roles. There is an increasing need for
outcome measures that capture change in activity performance and life participation.
Methods/Design: We will conduct a systematic review of the psychometric properties of instruments used to
measure upper limb functional outcomes (activity performance and participation) in patients with spasticity.
Assessments (n = 27) will be identified from a recently published systematic review of assessments that measure
upper limb function in neurological rehabilitation for adults with focal spasticity, and a systematic review of each
assessment will then be conducted. The databases MEDLINE, CINAHL and EMBASE will be searched from inception.
Search strategies will include the name of the assessment and the COnsensus-based Standards for the selection of
health status Measurement INstruments (COSMIN) published search strategy for identifying studies of measurement
properties. The methodological rigour of the testing of the psychometric quality of instruments will be undertaken
using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) checklist.
International Classification of Functioning, Disability and Health (ICF) definitions of impairment, activity and participation
will be used for content analysis of items to determine the extent to which assessments are valid measures of activity
performance and life participation. We will present a narrative synthesis on the psychometric properties and utility of all
instruments and make recommendations for assessment selection in practice.
Discussion: This systematic review will present a narrative synthesis on the psychometric properties and utility of
assessments used to evaluate function in adults with upper limb focal spasticity. Recommendations for assessment
selection in practice will be made which will aid clinicians, managers and funding bodies to select an instrument fit for
purpose. Importantly, appropriate assessment selection will provide a mechanism for capturing how applicable to
everyday life the outcomes from individualised rehabilitation programs for the upper limb really are.
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Spasticity is most commonly accepted as being a velocity-
dependent increase in stretch reflex with exaggerated
tendon jerks that occurs as one part of the upper motor
neurone syndrome [1]. Pandyan et al [2] more recently
redefined spasticity as disordered sensorimotor control,
resulting from an upper motor neurone lesion, presenting
as intermittent or sustained involuntary activation of mus-
cles. In recent years, there has been a recognition within
neuro-rehabilitation that spasticity management programs
must go well beyond treatment of impairments, in line
with contemporary understandings of health emerging
from the World Health Organisation’s International
Classification of Functioning, Disability and Health Frame-
work (ICF) [3]. This framework starts with the assumption
that health is not a state independent of individuals in the
context of everyday life; thus spasticity, a neuro-muscular
condition, cannot be considered independent of the person
who has it and their daily life. This makes understand-
ing, measuring and monitoring the impact of neuro-
rehabilitation programs on function in everyday life as
important as measuring and monitoring spasticity.
Contemporary neuro-rehabilitation uses the ICF as an
organising framework. Apart from the environment, there
are three domains in the classification—impairment, activ-
ity and participation [3]. The ICF defines “impairment” as
a problem in body (physiological and psychological) func-
tion or structure (anatomical parts of the body), “activity”
is the execution of a task or action by an individual and
“participation” is involvement in a life situation [3]. In
upper limb rehabilitation, function is an important and
debated term—because impairments can affect function
and it is through function that activity and participation
goals can be achieved. The term function is used variably
within the literature; it alludes to impairments, activity
performance and/or participation in life situations in
addition to associations with active task performance.
Whilst concepts associated with “function” can vary,
operationally, functional use of the spasticity-affected
upper limb has been defined by Ashford and Turner-
Stokes [4]. That is: active task performance; the affected
limb actively completes the task or passive task perform-
ance; the task is completed by the affected limb with as-
sistance from the unaffected limb or the task is assisted
with or completed by a carer; a key area for spasticity in-
terventions [4]. This three-part operational definition of
upper limb function is used in the present study.
Multi-disciplinary person-centred approaches are needed
to address rehabilitation needs at impairment, activity and
participation levels [5–7]. Neuro-rehabilitation clinical
practice guidelines recommend collaborative goal setting
[7–10], so that patient preferences and priorities can in-
form programs. Practice guidelines also recommend the
use of standardised assessments to measure impairment,activity and participation dimensions of performance
relevant to everyday real life [4, 6, 10, 11]. Although most
rehabilitation clinicians measure treatment outcomes [12],
evidence suggests that many have limited awareness of
the range of assessments available [13]. Those who do
use assessment use predominantly impairment-based
measures—few use measures that capture activity or par-
ticipation performance [6, 14]. There are measures avail-
able. Although an earlier systematic review of functional
outcome measures in the hemiparetic upper limb was
conducted in 2008 [15], this study was unable to identify a
single valid and reliable outcome measure that captured
“real life” function. But a more recent review by Ashford
and Turner-Stokes in 2013 [4] identified n = 27 functional
assessments used in upper limb neuro-rehabilitation for
people with spasticity (with and without botulinum toxin-A
injection). Their inclusion criteria required the assessments
to explore function in the context of everyday real life. As
yet, these assessments have not been appraised in relation
to the psychometric rigour or clinical utility [4, 16]. This
study aims to fill that gap.
This study will use the same n = 27 assessments from
the Ashford and Turner-Stokes study [4] to investigate
the psychometric properties of each and draw conclusions
regarding their relative rigour and relevance. A key focus
will be the validity of these assessments in their ability to
capture change in activity performance and life partici-
pation. The ICF will be used as the framework to appraise
assessment content to determine the extent to which items
address activity and participation domains in addition to
impairment (body structures and function). Determining
the content validity of items in relation to these domains is
important not only to see how valid the assessment is in
measuring “health” as it is defined by the ICF but also be-
cause these domains reflect common patient goals.
Common neuro-rehabilitation goals for people with
upper limb spasticity include reducing pain, increasing the
range of movement, preventing contractures and reducing
spasticity to enable movement training, splinting or cast-
ing [6, 12, 17]. Other goals relate to increasing a person’s
ability to perform activities and participate in their life
situation [6, 11, 16, 18–20]. To date, no systematic re-
view has done this.
Outcomes of this review will be helpful to clinicians
and researchers alike working with people who have upper
limb spasticity. Right now, some attention has been given
to neuro-rehabilitation for people with upper limb spasti-
city on function in everyday real life [11, 16], but it is a
relatively new focus of program evaluation [4, 10, 11] and
a challenging one [17, 20, 21]. Determining whether or
not interventions impact functional outcomes in everyday
life for people with upper limb spasticity has, to date, been
complicated by methodological problems, not just in rela-
tion to function but also spasticity measurement [15, 22]
Pike et al. Systematic Reviews  (2015) 4:86 Page 3 of 5and the use of weak study designs [17, 21]. There is a need
for more research to show that multidisciplinary upper
limb spasticity management rehabilitation programs have
an impact on the ability of people to perform activities in
everyday real life [11, 23, 24].
The objectives of this systematic review are to locate
and appraise existing evidence of the psychometric prop-
erties of the outcome measures identified by Ashford
and Turner-Stokes [4] and classify those measures to
conclude the best tool available for the purpose of meas-
uring activity performance and participation outcomes
following upper limb spasticity rehabilitation.
Methods/Design
This systematic review builds on the systematic search
conducted by Ashford and Turner-Stokes [4] by synthe-
sising and appraising the research of the psychometric
(measurement) properties of outcome measures reported
within the published paper. From the 22 studies located
in the published search [4], n = 33 assessment approaches
were identified. On review of those assessment approaches,
some were in fact developed for that particular study, for
example, three functional tasks (palm hygiene, cutting the
fingernails, placing an arm through the sleeve), and conse-
quently do not have published psychometric properties
and were excluded from the current study. The remaining
n = 27 outcome measures had published research investi-
gating their psychometric (measurement) properties and
will therefore form the sample for the present study. The
authors acknowledge the creation of a degree of assess-
ment selection bias due to this method.
The aims of this systematic review will be:
1. To classify the functional outcome measures reported
by Ashford and Turner-Stokes [4] according to
whether activity and or participation outcomes
following upper limb spasticity rehabilitation are
being assessed; activity performance and participation
will be defined according to the ICF model [3]; and
2. To locate all of the existing evidence of the
properties of the outcome measures, to evaluate the
strength of this evidence and to come to a conclusion
about the best measure available for the particular
purpose of measuring activity and/or participation
outcomes following upper limb spasticity rehabilitation.
Publication/study inclusion criteria
1. The aim of the study should be to develop or
evaluate the measurement properties of a
measurement instrument identified in the review
published by Ashford and Turner-Stokes [4];
2. The instrument should aim to measure activity
performance or participation, as defined by the ICF [3]Activity performance is defined as “the execution of
a task or action by an individual” or requires assistance
from or be completed by a carer for the individual.
Participation is defined as “involvement in a life
situation.”
3. The instrument is evaluated in adult patients, over
18 years of age, with upper limb spasticity (as defined
by the authors of the included studies) or patients
before or after botulinum toxin injection engaging in
upper limb rehabilitation programs (with or without
the inclusion of botulinum toxin therapy). A
rehabilitation program is one that is devised and
implemented by a clinician to work towards
achievement of identified goals. Participants can be
engaging in the rehabilitation program whilst a
hospital inpatient, transitioning to home or be
community dwelling.
4. All research studies must be original research, and
both conducted and published studies in English
within peer-reviewed literature will be considered
for this review.
Publication/study exclusion criteria
This review is concerned with outcomes of upper limb
spasticity rehabilitation that identify changes in the per-
formance of an activity or participation as defined by the
ICF [3]. Studies that measure activity performance and
participation will be included. Studies that measure upper
limb spasticity rehabilitation outcomes through assessment
of upper limb impairments only, including pain, range
of movement, contracture and changes in tone, will be
excluded. Outcomes that have been modified in any man-
ner or implemented in a language other than English will
be excluded.
Search methods for the identification of studies
A search will be conducted in Medical Literature Analysis
and Retrieval System Online (MEDLINE), Cumulative
Index to Nursing and Allied Health Literature (CINAHL)
and Excerpta Medica dataBASE (EMBASE). In MEDLINE,
a validated search filter for finding studies on measurement
properties will be used [25]; we report the planned
MEDLINE search strategy in Additional file 1. CINAHL
and EMBASE search strategies are available from the
authors on request. Searches with the names of each in-
cluded instruments (in the title) in combination with
the terms for the study population as described in the
search strategy [see Additional file 1] will be conducted
until each instrument has been searched.
Screening
Once all searches have been exhausted, the abstracts will
be downloaded into the reference management system
EndNote and duplicates deleted. A study deemed as a
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come measures implemented, date and duration of study
in common.
The eligibility criteria will first be applied to the title
and abstract, and if deemed relevant, the full manuscript
will be retrieved to determine eligibility of potential stud-
ies. The initial screen and selection will be completed in-
dependently by the first author with the second author
blindly screening a 10 % selection of articles for eligibility.
Debate on the inclusion or exclusion of studies will be re-
solved by an independent third reviewer and discussion
between all three reviewers to reach consensus.
Data management
Details on studies that were initially selected based on
title and abstract, full-text articles that were retrieved and
articles included in the review will be documented.
Reasons for the exclusion of retrieved full-text articles,
particularly in the case of doubtful articles, will also be
recorded.
Data extraction
Data will be extracted from selected studies by the first
author utilising a standardised data extraction form. This
form will record information related to participants, study
design, description of botulinum toxin therapy and re-
habilitation program (s), outcome measures administered
and their classification according to the ICF (activity
performance and or participation focus), psychometric
properties, study inclusion/exclusion criteria if available
and a brief summary of the findings. The second author
will crosscheck all COSMIN ratings.
Risk of bias assessment
Studies evaluating the measurement properties of an as-
sessment require high methodological quality with a low
risk bias to guarantee that appropriate conclusions are
drawn about the properties of the measure [25]. Thus, it
is important to evaluate those methodological qualities
[26]. This review will apply the COnsensus-Based Stan-
dards for the Selection of Health Status Measurement
INstruments (COSMIN) checklist with 4-point scale ver-
sion [27]. This version is recommended by the COSMIN
developers for use in systematic reviews of measurement
properties. The checklist will be applied to assess the qual-
ity of the papers reporting on the psychometric properties
of the 27 outcome measures, evaluating whether each
study meets the standards for methodological quality with
regard to internal consistency, reliability (test-retest, inter-
rater and intra-rater reliability), measurement error, con-
tent validity (including face validity), structural validity,
hypothesis testing, cross-cultural validity, criterion val-
idity, responsiveness, interpretability and generalisability
[27]. The 4-point scale will allow a methodological qualityrating of either “excellent”, “good”, “fair” or ”poor” to be
assigned to the study [27]. The COSMIN checklist was
developed in an international Delphi study with the focus
of evaluating the methodological quality of studies on
measurement properties [27]. The COSMIN checklist is a
modular tool, and the measurement properties evaluated
in the study will determine which components or “boxes”
need to be completed [27].Data analysis
Individual assessment items within the outcome measures
will be examined to extract meaningful concepts. Those
concepts will then be linked to the ICF framework cat-
egories of activity performance and or participation fol-
lowing the linking rules suggested by Cieza et al. [28]
[see Additional file 2]. This linking process will enable
the extent to which outcomes are valid measures of ac-
tivity performance and life participation to be determined.
The COSMIN checklist with 4-point scale version [27]
as described above will be applied to the selected studies,
as per COSMIN guidelines, to appraise the overall meth-
odological quality of studies. From here, Terwee’s quality
criteria for measurement properties [29] will be applied.
Quality criteria for the following nine measurement prop-
erties are defined; content validity, internal consistency,
criterion validity, construct validity, reproducibility, re-
liability, responsiveness, floor and ceiling effects and in-
terpretability. This data analysis process will enable
conclusions to be drawn regarding the strongest psy-
chometric measure available for the particular purpose
of evaluating activity and/or participation outcomes fol-
lowing upper limb rehabilitation. Differences in the psy-
chometric properties of outcome measures for patients
with and without upper limb spasticity will be discussed.Discussion
This systematic review will provide a comprehensive evalu-
ation of the measurement properties of outcome measures
assessing activity performance and participation goals for
adults with upper limb spasticity undergoing rehabilitation.
The results of this review will provide health professionals
with detailed information to guide clinical decision-making
when choosing the most appropriate outcome measure for
occupational performance. Rehabilitation clinicians and
managers will also be provided with information to
permit accurate assessment and monitoring of the re-
lationship between rehabilitation and health outcome
in these patients.Additional files
Additional file 1: Search strategy. MEDLINE search strategy.
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concepts to ICF as per linking rules.
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